Stakeholders’ Role in Contemporary “Substitute Drug” Prescribing Policies in Italy

By Beccaria Franca   Rolando Sara  

Substance Use & Misuse, Vol. 48, Iss. 11, 2013-09 ,pp. : 943-953

Informa Healthcare

Access to resources Recommend Favorite

PTAMs may help control early new drug prescribing

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 527, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Commentary on “Stakeholders’ Role in Contemporary ‘Substitute Drug’ Prescribing Policies in Italy” by Franca Beccaria and Sara Rolando

By Minutillo Adele   Zuccaro Piergiorgio  

Substance Use & Misuse, Vol. 48, Iss. 11, 2013-09 ,pp. : 1065-1066

Informa Healthcare

Access to resources Recommend Favorite

The Influence of Primary Care Prescribing Rates for New Drugs on Spontaneous Reporting of Adverse Drug Reactions

By Clark Richard C.  

Drug Safety, Vol. 30, Iss. 4, 2007-01 ,pp. : 357-366

Adis International

Access to resources Recommend Favorite

Therapeutic traditions, patient socioeconomic characteristics and physicians’ early new drug prescribing–a multilevel analysis of rosuvastatin prescription in south Sweden

By Ohlsson Henrik   Chaix Basile   Merlo Juan  

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite